Will We Be Ready for the Next War?
Author(s) -
George W. Christopher,
Mark G. Kortepeter
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ564
Subject(s) - medicine
TO THE EDITOR—The title of Dr Schooley’s editorial, “All’s (Almost) Quiet on the Western Front: Will We Be Ready for the Next War?” [1] raises a key question: What is the role of the US Department of Defense (DoD) in the Ebola outbreak response? Because Ebola is a biological warfare threat, theDoDhas been developingmedical countermeasures through its biological defense program for more than a decade. Six DoD-sponsored candidates, intended for biological defense under field conditions, were accelerated in collaboration with civilian partners to support outbreak response. The US Food and Drug Administration (FDA) granted Emergency Use Authorizations to 2 DoD-sponsored polymerase chain reaction–based diagnostic assays, EZ-1 and BT-E. DoD provides test kits to support African and US treatment centers; >20 000 kits are pre-positioned
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom